TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year EV/Net Sales History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
EV/Net Sales(x) | 4.49 | 5.58 | 0.47 |
What is the latest EV/Net Sales ratio of TRIDENT LIFELINE ?
Year | EV/Net Sales |
---|---|
Mar2024 | 4.49 |
Mar2023 | 5.58 |
Mar2022 | 0.47 |
How is EV/Net Sales of TRIDENT LIFELINE Trending?
Years | EV/Net Sales | % Change | |
---|---|---|---|
Mar2024 | 4.49 | -19.53 | |
Mar2023 | 5.58 | 1,087.23 | |
Mar2022 | 0.47 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Net Sales ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹313.2 Cr | -7.5% | 1.8% | 78.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -7.5% |
1.8% |
78.6% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses